Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: Correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma

Laboratory Investigation

Volumn 81, Issue 4, 2001, Pages 573-579

  Kang, Joo Hyun ^a   Kim, Sun Jung ^b   Noh, Dong Young ^c   Park, In Ae ^c   Choe, Kuk Jin ^c   Yoo, Ook Joon ^a   Kang, Han Sung ^d  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Dongguk University   (South Korea)

^c Seoul National University   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; MUTANT PROTEIN; PROTEIN P53;

ARTICLE; BINDING SITE; BREAST CARCINOGENESIS; CANCER GROWTH; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION FUNCTION; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 0035049323     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780266     Document Type: Article

References (27)

1. Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice
2. The 5′ region of the p53 gene: Evolutionary conservation and evidence for a negative regulatory element
3. The essentials of DNA methylation
4. Protein-binding elements in the promoter region of the mouse p53 gene
5. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
6. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
7. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
8. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
9. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
10. DNA methylation and mutation
11. p53 mutations in human cancers
12. Modulation of liver-specific transcription by interactions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition
13. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max
14. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas
15. Methylation analysis using bisulfite genomic sequencing: Application to small numbers of intact cells
16. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
17. Differential binding of NF-1 transcription factor to P53 gene promoter and its depletion in human breast tumours
18. Post-transcriptional down-regulation of expression of transcription factor NF-1 by Ha-ras oncogene
19. Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: Possible in vivo relevance during tumorigenesis
20. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif
21. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene
22. Loss of p53 function through PAX-mediated transcriptional repression
23. Characterization of the human p53 gene promoter
24. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
25. Interaction of DNA-binding proteins with a milk protein gene promoter in vitro: Identification of a mammary gland-specific factor
26. p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas
27. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size